Mutation detail:
| Mutation site | G339D |
| Virus | SARS-CoV-2 |
Mutation level  |
Amino acid level |
| Gene/protein/region type | S |
| Gene ID | 43740568 |
| Country | - |
| Mutation type |
nonsynonymous mutation |
| Genotype/subtype/clade | - |
| Sample |
cell line |
| Variants | Omicron |
| Viral reference sequence | NC_045512.2 |
| Drug/antibody/vaccine | BD55-3451-NAb resistant, BD55-4281-NAb resistant |
| Transmissibility |
- |
| Transmission mechanism | - |
| Pathogenicity |
- |
| Pathogenicity mechanism | - |
| Immune escape mutation | Yes |
| Immune escape mechanism | - |
| RT-PCR primers probes | - |
Protein detail:
| Protein name | Spike glycoprotein |
| Uniprot protein ID | P0DTC2 |
| Protein length | 1273 amino acids |
| Protein description | Spike protein is one of the structural proteins of SARS-CoV-2. The monomeric protein consists of one large ectodomain, a single-pass transmembrane anchor, and a short intracellular tail at C-terminus. It encompasses 22 glycosylation sites. S protein cleaves into two subunits namely S1 and S2 following receptor recognition. Receptor Binding Domain (RBD) in S1 subunit plays a major role in ACE2 receptor binding. |
Literature information:
| Pubmed ID | 35016194 |
| Clinical information | No |
| Disease | - |
| Published year | 2022 |
| Journal | Nature |
| Title | Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies |
| Author | Yunlong Cao, Jing Wang, Fanchong Jian, Tianhe Xiao, Weiliang Song |
| Evidence | The receptor-binding domain, responsible for interacting with the Angiotensin-Converting Enzyme 2 (ACE2) receptor, bears 15 of these mutations, including G339D, S371L, S373P, S375F, K417N, N440K, G446S, S477N, T478K, E484A, Q493R, G496S, Q498R, N501Y, and Y505H. |